| Filed On | Filing |
|---|---|
| 17 Sep 2026 |
Form 3: Meyer Robert J., Director
No securities owned |
| 29 Apr 2026 | Form 3: Wellington Biomedical Innovation Master Investors (Cayman) Ii L.p., 10% owner |
| 29 Apr 2026 | Form 3: Novo Holdings A/S, 10% owner |
| 29 Apr 2026 | Form 3: Fmr Llc, 10% owner |
| 29 Apr 2026 | Form 3: Sr One Capital MANAGEMENT, Llc, 10% owner and 1 other |
| 29 Apr 2026 | Form 3: Carroll Jill, Director |
| 29 Apr 2026 | Form 3: Lavelle Erin, Director |
| 29 Apr 2026 | Form 3: Congleton Jon, Director |
| 29 Apr 2026 |
Form 3: Friedman David Matthew, Director
No securities owned |
| 29 Apr 2026 | Form 3: Rhodes Melissa, Chief Operating Officer |
| 29 Apr 2026 | Form 3: Turner Heather D, Director |
| 29 Apr 2026 | Form 3: Lazarus Howard, Chief Medical Officer |
| 29 Apr 2026 | Form 3: Haviland Kate, Director |
| 29 Apr 2026 | Form 3: Carlson Douglas R, See Remarks |
| 29 Apr 2026 | Form 3: Baranowski Lyn, Director |
| 29 Apr 2026 |
Form 3: Golden Adam H., General Counsel
No securities owned |
Loading...
